Perspectives of Non-Pharmacy Professionals in Long-Term Care Facilities on Pharmacist-Involved Medication Management in South Korea: A Qualitative Study
Abstract
:1. Introduction
2. Materials and Methods
2.1. Study Design and Participants
2.2. Researchers and Interviewer
2.3. Data Collection
2.4. Data Analysis and Reports
3. Results
3.1. Needs
3.1.1. Intrinsic Factors
Necessity
(Medication is) absolutely important. Whether the elderly people die or live depends on the medications. (Participant #1, 269, 270)
Polypharmacy
We were shocked (by the number of the medications). Some residents brought so many drugs with themselves when they were discharged from their hospitals, about 15 medications or even more than 20 drugs at a time. In my view, that’s pretty excessive. That’s too many. Some residents brought 3 or 4 types of expectorants even though they didn’t have cough or sputum. (Participant #2, 119–121)
Diversity
Even when we use a simple drug, like acetaminophen, some people respond to only 300 mg while others do not respond to even 2 g a day. […] In my view, older people may show various responses to the same drug, dramatic effects or none, even if the dose is based on the textbook. (Participant #3, 109–111, 114–116)
3.1.2. Environmental Factors
Physicians as Sole Decision Makers
Realistically speaking, (among physicians) they don’t really know much about drugs on the market, and also if it’s not within their specialties, they don’t really know the details about the drug or interactions of the drugs. (Participant #3, 161–163)
Limited Role of Pharmacists
Only 16 hours. Because pharmacists work for a very short period of time, pharmacists are not involved in drug management at all […] Someone should take the role of being a bridge between doctors and residents, or other staff, but it’s quite burdensome for us to take that responsibility because we are not experts in medications […] In my view, pharmacists are too busy filling prescriptions during their shifts. (Participant #5, 51, 52, 63, 64, 101)
Practitioners’ Lack of Awareness
(Caregivers) sometimes are careless about medications. “Skipping once won’t hurt” or when they drop a pill while opening the drug packet, they show careless behavior thinking, “it’s just one pill, it’s okay” by throwing the pill in the trash can. (Participant #1, 316–318)
3.2. Expectations
3.2.1. Medication Review/Reconciliation
Just doing a lot of drug–drug interaction reviews can be adequately helpful. (Participant #8, 330)
The pharmacist’s drug management could include comparing the resident’s condition and the drugs currently being prescribed along with making sure that no unnecessary drugs are being used on a resident, (and) duplicated therapy. (Participant #1, 245–247)
3.2.2. Education/Counseling
Pharmacists need to question if the healthcare team members know the importance of the medication and to provide education courses twice a month or at least every quarter for re-emphasizing the importance of the drug and its management over and over again. (Participant #1, 453–456)
If pharmacists can explain adverse drug reactions, so if it can lead residents to recognize and notice (adverse drug reactions) early, it will be good for doctors to treat it. “How to take medicines appropriately” and “adverse drug reactions”, I think that these two points are really, really important. (Participant #9, 179–182)
3.3. Barriers
3.3.1. Authorization of Pharmacist Roles
Whether we want to do it or not, it is necessary to establish pharmacists’ roles (in LTCFs) by law and then we can abide by the rules. In fact, it is a desirable direction for promoting public health. (Participant #3, 368–370)
Practically speaking, it is difficult. We already receive a regular evaluation every two years, there are close to 100 evaluation items, it’s really hard for us. […] If there is something new in the regulations without any consistent direction, it can be very difficult. (Participant #11, 388–390, 393–394)
3.3.2. Financial Stability of LTCFs
We are somewhat dependent on money. It is, in fact, quite a burden for facilities to hire a pharmacist by spending a lot of money [...] The government should not be talking about developing pharmacists’ roles but providing actual support for the employment of pharmacists. It seems like the burden ultimately is on facilities because the government is simply laying the blame on facilities without providing any support. In some way, it is necessary to have a support system at the government level. (Participant #5, 104, 105, 112–116)
3.3.3. Professional Development of Pharmacists
What is important will be the work experience. A pharmacist should be experienced because geriatric medication differs according to each resident. It is important not to be theoretical but also to have clinical experience because it is important to understand the disease conditions, characteristics, and progression in each resident. In that respect, I think that some practical experiences as well as theoretical education are needed. (Participant #6, 243–247)
3.3.4. Role Awareness among Coworkers
It would be necessary to recognize, value, and share each profession’s role in order to specify what we have talked about so far. (Participant #4, 551, 552)
4. Discussion
5. Conclusions
Author Contributions
Funding
Acknowledgments
Conflicts of Interest
Appendix A
Item | Description |
---|---|
Domain 1: Research team and reflexivity | |
Personal characteristics | |
1. Interviewer/facilitator | K.K. |
2. Credentials | Pharmacist, Ph.D. |
3. Occupation | Faculty (College of Pharmacy) |
4. Gender | Female |
5. Experience and training | Currently conducting research in pharmacy practice in a college of pharmacy; previously worked in a hospital pharmacy and community pharmacy as a pharmacist |
Relationship with participants | |
6. Relationship established | No prior relationship existed between the interviewer and the participants. Participants were recruited by snowball sampling. |
7. Participant knowledge of the interviewer | The participants did not know the interviewer prior to their interview. The interviewer introduced herself and explained the goals of the research prior to their in-depth interview. |
8. Interviewer characteristics | The interviewer is a professor at a college of pharmacy and conducts research about the role of pharmacists in geriatric care. |
Domain 2: Study design | |
Theoretical framework | |
9. Methodological orientation and theory | Inductive thematic analysis using a codebook |
Participant selection | |
10. Sampling | Participants were recruited by snowball sampling. |
11. Method of approach | Telephone and e-mail |
12. Sample size | Physicians: 4; registered nurses: 3; social workers: 5 |
13. Nonparticipation | No participant withdrew from participating in the study. |
Setting | |
14. Setting of data collection | Workplace of participant |
15. Presence of nonparticipants | No nonparticipants |
16. Description of sample | Presented in Table 3 |
Data collection | |
17. Interview guide | Presented in Table 2. Semi-structured interview guide was written by K.K. and reviewed by J.M.O. |
18. Repeat interviews | No |
19. Audio/Visual recording | All in-depth interviews were audio recorded and transcribed verbatim. |
20. Field notes | Field notes were made during the interviews by A.K. when necessary. |
21. Duration | In-depth interviews took 41–88 min per participant. |
22. Data saturation | Data were collected until thematic saturation was reached and no new themes were emerging. |
23. Transcripts returned | The transcripts were returned to each participant, and the participants were asked to check them for accuracy. |
Domain 3: Analysis and findings | |
Data analysis | |
24. Number of data coders | Two (A.K. and K.K.) |
25. Description of coding tree | For data analysis, two authors (A.K. and K.K.) repeatedly reviewed the interview transcript to identify inductively emergent codes and to assess connections amongst the codes to identify themes. During this process, they made a codebook with code labels and definitions. The codebook was refined iteratively with repeat transcript coding by and consultative discussions with the authors to ensure methodological rigor. |
26. Derivation of themes | Themes were derived from the data. A.K., K.K., and the other authors discussed the emergence of the themes during the data analysis process. |
27. Software | Excel |
28. Participant checking | No feedback was sought from participants on the findings |
Reporting | |
29. Quotations presented | Yes, including the participant reference number |
30. Data and findings consistent | Yes |
31. Clarity of major themes |
|
32. Clarity of minor themes |
|
References
- Davies, E.A.; O’Mahony, M.S. Adverse drug reactions in special populations—The elderly. Br. J. Clin. Pharmacol. 2015, 80, 796–807. [Google Scholar] [CrossRef] [PubMed]
- Mangoni, A.A.; Jakson, S.H. Age-related changes in pharmacokinetics and pharmacodynamics: Basic principles and practical applications. Br. J. Clin. Pharmacol. 2004, 57, 6–14. [Google Scholar] [CrossRef] [PubMed]
- Locca, J.-F.; Ruggli, M.; Buchmann, M.; Huguenin, J.; Bugnon, O. Development of pharmaceutical care services in nursing homes: Practice and research in a Swiss canton. Pharm. World Sci. 2009, 31, 165–173. [Google Scholar] [CrossRef] [PubMed]
- State Operation Manual (SOM). Available online: https://www.cms.gov/Regulations-and-Guidance/Guidance/Manuals/Internet-Only-Manuals-IOMs-Items/CMS1201984.html. (accessed on 13 April 2019).
- Levenson, S.A.; Saffel, D.A. The consultant pharmacist and the physician in the nursing home: Roles, relationships, and a recipe for success. J Am. Med. Dir. Assoc. 2007, 8, 55–64. [Google Scholar] [CrossRef] [PubMed]
- Zermansky, A.G.; Silcock, J. Is medication review by primary-care pharmacists for older people cost effective? A narrative review of the literature, focusing on costs and benefits. Pharmacoeconomics 2009, 27, 11–24. [Google Scholar] [CrossRef] [PubMed]
- Chia, H.S.; Ho, J.A.H.; Lim, B.D. Pharmacist review and its impact on Singapore nursing homes. Singap. Med. J. 2015, 56, 493. [Google Scholar] [CrossRef] [PubMed]
- Jodar-Sanchez, F.; Martin, J.J.; Lopez del Amo, M.P.; Garcia, L.; Araujo-Santos, J.M.; Epstein, D. Cost-utility analysis of a pharmacotherapy follow-up for elderly nursing home residents in Spain. J. Am. Geriatr. Soc. 2014, 62, 1272–1280. [Google Scholar] [CrossRef] [PubMed]
- Patterson, S.M.; Hughes, C.M.; Cardwell, C.; Lapane, K.L.; Murray, A.M.; Crealey, G.E. A cluster randomized controlled trial of an adapted U.S. model of pharmaceutical care for nursing home residents in Northern Ireland (Fleetwood Northern Ireland study): A cost-effectiveness analysis. J. Am. Geriatr. Soc. 2011, 59, 586–593. [Google Scholar] [CrossRef] [PubMed]
- National Statistics Office. 2017 Statistics on the Aged. Available online: http://kostat.go.kr/portal/eng/pressReleases/11/3/index.board?bmode=read&bSeq=&aSeq=363974&pageNo=1&rowNum=10&navCount=10&currPg=&sTarget=title&sTxt=. (accessed on 2 June 2018).
- Ministry of Health and Welfare. Enforcement Rule of the Medical Service Act; Article 38, Attached Table 5–2; Ministry of Health and Welfare: Sejong, Korea, 2017.
- Tong, A.; Sainsbury, P.; Craig, J. Consolidated criteria for reporting qualitative research (COREQ): A 32-item checklist for interviews and focus groups. Int. J. Qual. Health Care 2007, 19, 349–357. [Google Scholar] [CrossRef]
- DeCuir-Gunby, J.T.; Marshall, P.L.; McCulloch, A.W. Developing and using a codebook for the analysis of interview data: An example from a professional development research project. Field Methods 2011, 23, 136–155. [Google Scholar] [CrossRef]
- U.S. Department of Health and Human Services. Agency for Healthcare Research and Quality (AHRQ) Glossary. Available online: https://www.ahrq.gov/patients-consumers/patient-involvement/ask-your-doctor/tips-and-tools/glossary.html. (accessed on 13 July 2018).
- Kim, S.O.; Jang, S.; Kim, C.M.; Kim, Y.R.; Sohn, H.S. Consensus Validated list of potentially inappropriate medication for the elderly and their prevalence in South Korea. Int. J. Gerontol. 2015, 9, 136–141. [Google Scholar] [CrossRef]
- Hwang, H.J.; Kim, S.H.; Lee, K.S. Potentially inappropriate medications in the elderly in Korean long-term care facilities. Drugs Real World Outcomes 2015, 2, 355–361. [Google Scholar] [CrossRef] [PubMed]
- Ruths, S.; Straand, J.; Nygaard, H. Multidisciplinary medication review in nursing home residents: What are the most significant drug-related problems? The Bergen District Nursing Home (BEDNURS) study. Qual. Saf. Health Care 2003, 12, 176–180. [Google Scholar] [CrossRef] [PubMed]
- Furniss, L.; Burns, A.; Craig, S.K.; Scobie, S.; Cooke, J.; Faragher, B. Effects of a pharmacist’s medication review in nursing homes. Randomised controlled trial. Br. J. Psychiatry. 2000, 176, 563–567. [Google Scholar] [CrossRef] [PubMed]
- Trygstad, T.K.; Christensen, D.B.; Wegner, S.E.; Sullivan, R.; Garmise, J.M. Analysis of the North Carolina long-term care polypharmacy initiative: A multiple-cohort approach using propensity-score matching for both evaluation and targeting. Clin. Ther. 2009, 31, 2018–2037. [Google Scholar] [CrossRef]
- Lee, I.H.; Rhie, S.J.; Je, N.K.; Rhew, K.Y.; Ji, E.; Oh, J.M.; Lee, E.; Yoon, J.H. Perceived needs of pharmaceutical care services among healthcare professionals in South Korea: A qualitative study. Int. J. Clin. Pharm. 2016, 38, 1219–1229. [Google Scholar] [CrossRef]
- Tan, E.C.; Stewart, K.; Elliott, R.A.; George, J. Integration of pharmacists into general practice clinics in Australia: The views of general practitioners and pharmacists. Int. J. Pharm. Pract. 2014, 22, 28–37. [Google Scholar] [CrossRef]
- McDonough, R.P.; Doucette, W.R. Building working relationships with providers. J. Am. Pharm. Assoc. 2003, 43 (Suppl. 1), S44–S45. [Google Scholar]
- Nam, H.Y.; Cho, E. A Systematic Review on the certified geriatric pharmacist program of the U.S.: Certification, education and outcomes. Yakhak Hoeji 2014, 58, 129–140. [Google Scholar]
- Patterson, B.J.; Solimeo, S.L.; Stewart, K.R.; Rosenthal, G.E.; Kaboli, P.J.; Lund, B.C. Perceptions of pharmacists’ integration into patient-centered medical home teams. Res. Soc. Adm. Pharm. 2015, 11, 85–95. [Google Scholar] [CrossRef] [PubMed]
- Schindel, T.J.; Yuksel, N.; Breault, R.; Daniels, J.; Varnhagen, S.; Hughes, C.A. Perceptions of Pharmacists’ Roles in the Era of Expanding Scopes of Practice. Res. Soc. Adm. Pharm. 2017, 13, 148–161. [Google Scholar] [CrossRef] [PubMed]
- Long-Term Care for Older Persons in the Republic of Korea. Long-term care for older persons in Asia and the Pacific 2015. Available online: http://www.unescap.org/resources/long-term-care-older-persons-republic-korea. (accessed on 13 July 2018).
- Lau, W.M.; Chan, K.; Yung, T.H.; Lee, A.S. Outreach pharmacy service in old age homes: A Hong Kong experience. J. Chin. Med. Assoc. 2003, 66, 346–354. [Google Scholar] [PubMed]
Introduction |
I want to thank you for taking the time to meet with me today. My name is Kyungim Kim. I’m a faculty member at a college of pharmacy and also a pharmacist. I would like to talk to you about your experience in long-term care facilities. The purpose of this in-depth interview is to hear your thoughts and opinions about pharmacist-involved medication management in long-term care facilities. The interview will take less than an hour. This interview will be audio recorded because I do not want to miss any of your comments. Although I will be taking some notes during the session, I can’t write fast enough to get it all down. We are on tape, so please be sure to speak up so that we don’t miss your comments. All responses will be kept confidential. This means that your interview responses will only be shared with research team members and we will ensure that any information we include in our report does not identify you as the respondent. There are no right or wrong answers to my questions. Please feel free to share your opinions. Remember, you don’t have to talk if you do not want to and you may end the interview at any time. Are there any questions about what I have just explained? Are you willing to participate in this interview? |
Questions |
|
Closing |
Is there anything more you would like to add? Thank you for your time. |
Variable | N |
---|---|
Gender | |
Male | 5 |
Female | 7 |
Age | |
30–39 | 2 |
40–49 | 2 |
50–59 | 6 |
60–69 | 2 |
Occupation | |
Physician | 4 |
Registered nurse | 3 |
Social worker | 5 |
Institution a | |
Geriatric care hospital | 5 |
Assisted living facility | 8 |
Practice location b | |
Seoul | 4 |
Gyeonggi | 8 |
Years in LTCF practice | |
<5 | 4 |
5–10 | 8 |
Setting | |
With on-site pharmacist (part-time) | 5 |
Without on-site pharmacist | 7 |
Thematic Category | Definition |
---|---|
Theme 1 | |
1. Needs | Situation where a pharmacist-involved medication management is needed |
Code | |
1.A. Intrinsic factors | Factors that contribute to the need for pharmacist-involved medication management due to the characteristics of the geriatric residents |
1.B. Environmental factors | Factors that contribute to the need for pharmacist-involved medication management due to the environment of LTCFs |
Theme 2 | |
2. Expectations | Services expected from the pharmacist involved in medication management |
Code | |
2.A. Medication review/reconciliation | Medication review during residence or at the time of admission, transfer, and discharge for the provision of appropriate feedback |
2.B. Education/counseling | Formal or informal education/counseling about medications for staff members and residents |
Theme 3 | |
3. Barriers | Barriers to be overcome to make pharmacist-involved medication management feasible in practice |
Code | |
3.A. Authorization | Authorized role or responsibility of pharmacists in LTCFs in developing pharmacist-involved medication management |
3.B. Finance | Financial stability of LTCFs in developing pharmacist-involved medication management |
3.C. Professional development | Pharmacists’ professional development in providing pharmacist-involved medication management |
3.D. Awareness | Mutual understanding/awareness among the staff members in developing pharmacist-involved medication management |
© 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
Share and Cite
Kwak, A.; Lee, E.; Oh, J.M.; Ji, E.; Kim, K. Perspectives of Non-Pharmacy Professionals in Long-Term Care Facilities on Pharmacist-Involved Medication Management in South Korea: A Qualitative Study. Int. J. Environ. Res. Public Health 2019, 16, 1977. https://doi.org/10.3390/ijerph16111977
Kwak A, Lee E, Oh JM, Ji E, Kim K. Perspectives of Non-Pharmacy Professionals in Long-Term Care Facilities on Pharmacist-Involved Medication Management in South Korea: A Qualitative Study. International Journal of Environmental Research and Public Health. 2019; 16(11):1977. https://doi.org/10.3390/ijerph16111977
Chicago/Turabian StyleKwak, Arim, Euni Lee, Jung Mi Oh, Eunhee Ji, and Kyungim Kim. 2019. "Perspectives of Non-Pharmacy Professionals in Long-Term Care Facilities on Pharmacist-Involved Medication Management in South Korea: A Qualitative Study" International Journal of Environmental Research and Public Health 16, no. 11: 1977. https://doi.org/10.3390/ijerph16111977
APA StyleKwak, A., Lee, E., Oh, J. M., Ji, E., & Kim, K. (2019). Perspectives of Non-Pharmacy Professionals in Long-Term Care Facilities on Pharmacist-Involved Medication Management in South Korea: A Qualitative Study. International Journal of Environmental Research and Public Health, 16(11), 1977. https://doi.org/10.3390/ijerph16111977